Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple Sclerosis: Methods and Protocols. Preface.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
[Visual neurorehabilitation of patients with cerebral damage using botulinum toxin].
Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.
Mimotopic peptide immunotherapy for the treatment of multiple sclerosis, an inflammatory autoimmune disease.
Uptake of environmental toxicants by the locus ceruleus: A potential trigger for neurodegenerative, demyelinating and psychiatric disorders.
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
A systematic review of factors associated with accidental falls in people with multiple sclerosis: a meta-analytic approach.
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-beta.
Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review.
MRI outcomes in the diagnosis and disease course of multiple sclerosis.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, Validity, and Factor Structure of the Persian Version.
Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.
Poor responses to interferon-Beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
Pain in neuromyelitis optica-prevalence, pathogenesis and therapy.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
Acute hypoxic-ischemia in cardiac arrest encephalopathy causes only minimal demyelination.
Increase in multiple sclerosis activity after assisted reproduction technology.
[Differntial diagnosis of neuromyelitis optica].
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
The ideal healthcare: priorities of people with chronic conditions and their carers.
Update on Leukodystrophies: A Historical Perspective and Adapted Definition.
Pages
« first
‹ previous
…
633
634
635
636
637
638
639
640
641
…
next ›
last »